When was Transmutex founded?

Transmutex was founded in 2019 and raised its 1st funding round 2 years after it was founded.

Where is Transmutex located?

Transmutex is headquartered in Geneva, Switzerland.

Who is the current CEO of Transmutex?

Franklin Franklin Servan-Schreiber of Transmutex. They have also founded 1 company.

How many employees does Transmutex have?

As of Jul 31, 2026, the latest employee count at Transmutex is 55.

Is Transmutex a funded company?

Transmutex is a funded company, having raised a total of $31.9M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 2021.

When was the latest funding round of Transmutex?

Transmutex's latest funding was a $***** Series A round on Jan 29, 2024, with participation from 10 investors.

Where does Transmutex rank among its competitors?

Transmutex ranks 1st amongst 2 active competitors, only 1 of which is funded. Transmutex, which secured $23.1M in Jan, 2024.

Transmutex - 2026 Company Profile, Team, Funding & Competitors

Transmutex is a series A company based in Geneva (Switzerland), founded in 2019 by Franklin Franklin Servan-Schreiber and Federico Carminati. It operates as a Developer of accelerator-powered technology for nuclear waste remediation and medical isotope production. Transmutex has raised $31.9M in funding from investors like Union Square Ventures, Fongit and Steel Atlas.

Company Details

Developer of accelerator-powered technology for nuclear waste remediation and medical isotope production. This technology transforms nuclear waste into clean energy, significantly reducing its volume and radiotoxicity. It also produces radioisotopes for use in medical diagnostics and treatment. The resulting energy can be utilized for district heating or electricity generation. The process offers enhanced safety and proliferation resistance while promoting environmental sustainability.

Website: www.transmutex.com/
Social
Email ID: *****@transmutex.com

Key Metrics

Founded Year

2019

Location

Geneva, Switzerland

Stage

Series A

Total Funding

$31.9M in 4 rounds

Latest Funding Round

Series A, Jan 29, 2024, $*****

Investors

Union Square Ventures & 11 more

Ranked

1^st among 2 active competitors

Employee Count

55 as on Jul 31, 2026

Similar Companies

Su-N

View Transmutex's full profile

Transmutex has raised a total funding of $31.9M over 4 rounds. Its first funding round was on May 2021. Its latest funding round was a Series A round on Jan 29, 2024 for $*****. 10 investors participated in its latest round. Transmutex has 12 institutional investors.

Here is the list of recent funding rounds of Transmutex:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 29, 2024	1770837	Series A	9681088	8511346	6173461	4973617
Jul 12, 2022	4536206	Series A	9904139	7875884	3597199	9604899
Jul 27, 2021	2584154	Series A	2526623	9055769	Union Square Ventures	AlleyCorp

Access funding benchmarks and valuations. Sign up today!

View details of Transmutex's funding rounds and investors

The founders of Transmutex are Franklin Franklin Servan-Schreiber and Federico Carminati. Franklin Franklin Servan-Schreiber is the CEO of Transmutex.

Here are the details of Transmutex's key team members:

Franklin Franklin Servan-Schreiber: Co-Founder & CEO of Transmutex.
Contact Info: 1 email address
Federico Carminati: Co-Founder of Transmutex.

View details of Transmutex's Founder profiles and Board Members

Transmutex's employee count trend

Transmutex has 55 employees as of Jul 26. Here is Transmutex's employee count trend over the years:

Uncover Transmutex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Transmutex include Su-N. Here is the list of Top 10 competitors of Transmutex, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Transmutex 2019, Geneva (Switzerland), Series A	Developer of accelerator-powered technology for nuclear waste remediation and medical isotope production	$31.9M	Fongit, Union Square Ventures & 10 others	53/100
2nd	Su-N United Kingdom, Unfunded	Developer of transmutation technology for clean energy, waste reduction, radioisotopes	-	-	16/100